Submission Details
| 510(k) Number | K181464 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 2018 |
| Decision Date | August 31, 2018 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K181464 is an FDA 510(k) clearance for the LIAISON Helicobacter Antigen, LIAISON Helicobacter Antigen Control Set, a Helicobacter Pylori (Class I — General Controls, product code LYR), submitted by DiaSorin, Inc. (Stillwater,, US). The FDA issued a Cleared decision on August 31, 2018, 88 days after receiving the submission on June 4, 2018. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3110.
| 510(k) Number | K181464 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 2018 |
| Decision Date | August 31, 2018 |
| Days to Decision | 88 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LYR — Helicobacter Pylori |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3110 |